The Healthcare Investor

Latest from The Healthcare Investor - Page 30

The interview below is part of a McGuireWoods series featuring interviews with C-suite leadership of private equity-backed portfolio companies. To recommend a leader for a future interview, email Holly Buckley at hbuckley@mcguirewoods.com or Tim Fry at tfry@mcguirewoods.com.

Q: Can you tell us about Ambulatory Management Solutions (AMS)?

Scott Mayer (SM): AMS is an outpatient anesthesia

Gurnet Point Capital and Novo Holdings have completed their acquisition of Paratek Pharmaceuticals in a deal valued at $462 million, according to a news release.

Paratek, founded in 1996 and based in Boston, is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for life-threatening diseases and other public health

COMPLIMENTARY WEBINARTuesday, October 24, 202312-1 p.m. (ET) | 11 a.m.-12 p.m. (CT) | 9-10 a.m. (PT)

Join McGuireWoods attorneys Amber McGraw Walsh and Kayla McCann Marty for a discussion of the payor services market. Their webinar will cover:

  • Key components of the payor services market
  • Challenges that drive payor services growth
  • Key legal topics for

Bain Capital Private Equity will acquire Harrington Process Solutions, according to a news release.

Harrington, founded in 1959 and based in Chino, Calif., is a specialty distributor of industrial flow control process solutions. Harrington provides solutions to a wide range of industries, including life sciences.

Bain Capital Private Equity, based in Boston, focuses

Surge Private Equity has announced it has invested in Elite Clinical Network (ECN) in a transaction valued at around $200 million.

ECN, founded in 2003 and based in Las Vegas, is a network of pharmaceutical research sites throughout California, Arizona and Nevada.

Surge, based in Dallas, is lower middle market equity firm pursuing investments